Found: 17
Select item for more details and to access through your institution.
Deferiprone-induced agranulocytosis: 20 years of clinical observations.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. 1026, doi. 10.1002/ajh.24479
- By:
- Publication type:
- Article
Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspective.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Cost-Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 9, p. 807, doi. 10.1007/s40273-013-0076-z
- By:
- Publication type:
- Article
Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone.
- Published in:
- Journal of Neurochemistry, 2015, v. 135, n. 5, p. 958, doi. 10.1111/jnc.13292
- By:
- Publication type:
- Article
Deferiprone in Friedreich ataxia: A 6-Month randomized controlled trial.
- Published in:
- Annals of Neurology, 2014, v. 76, n. 4, p. 509, doi. 10.1002/ana.24248
- By:
- Publication type:
- Article
Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 1988, v. 44, n. 3, p. 254, doi. 10.1038/clpt.1988.147
- By:
- Publication type:
- Article
Temporal variation in the disposition of theophylline and its metabolites.
- Published in:
- Clinical Pharmacology & Therapeutics, 1985, v. 38, n. 1, p. 89, doi. 10.1038/clpt.1985.140
- By:
- Publication type:
- Article
Ceftazidime disposition in acute and stable cystic fibrosis.
- Published in:
- Clinical Pharmacology & Therapeutics, 1984, v. 36, n. 3, p. 355, doi. 10.1038/clpt.1984.187
- By:
- Publication type:
- Article
Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074414
- By:
- Publication type:
- Article
Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarction.
- Published in:
- Basic Research in Cardiology, 2020, v. 115, n. 3, p. 1, doi. 10.1007/s00395-020-0782-6
- By:
- Publication type:
- Article
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 3, p. 593, doi. 10.1111/bcp.13134
- By:
- Publication type:
- Article
Effects of renal impairment on the pharmacokinetics of orally administered deferiprone.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 4, p. 994, doi. 10.1111/bcp.13037
- By:
- Publication type:
- Article
Transport of iron chelators and chelates across MDCK cell monolayers: implications for iron excretion during chelation therapy.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Charging for services.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Theophylline-7β-D-Ribofuranoside (Theonosine), a New Theophylline Metabolite Generated in Human and Animal Lung Tissue.
- Published in:
- Pharmaceutics, 2017, v. 9, n. 3, p. 28, doi. 10.3390/pharmaceutics9030028
- By:
- Publication type:
- Article
Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0154842
- By:
- Publication type:
- Article